Alx Oncology Holdings (ALXO) Interest & Investment Income (2022 - 2026)
Alx Oncology Holdings (ALXO) reported Interest & Investment Income of $1.2 million for Q1 2026, down 20.3% on a YoY basis from $1.5 million in Q1 2025, and up 106.28% sequentially from $573000.0 in Q4 2025.
Alx Oncology Holdings (ALXO) Interest & Investment Income (2022 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 5 years of Interest & Investment Income data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 20.3% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 55.51% YoY), and the FY2025 full-year result was $4.0 million, down 57.68% from the prior year.
- Interest & Investment Income advanced to $1.2 million in Q1 2026, from $573000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q4 2023 to a low of -$650000.0 in Q2 2022.
- A 5-year average of $937411.8 and a median of $802000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income sank 130.12% in 2024 and surged 750.44% in 2025, its largest moves.
- Tracing ALXO's Interest & Investment Income over 5 years: stood at $1.8 million in 2022, then soared by 65.74% to $3.0 million in 2023, then plunged by 37.3% to $1.9 million in 2024, then sank by 69.49% to $573000.0 in 2025, then surged by 106.28% to $1.2 million in 2026.
- Business Quant data shows ALXO's Interest & Investment Income at $1.2 million in Q1 2026, $573000.0 in Q4 2025, and $802000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Alx Oncology Holdings | 211.40 Mn | 211.40 Mn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 802,000.00 |
| Jun 30, 2025 | -82,000.00 |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -228,000.00 |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | -224,000.00 |
| Mar 31, 2023 | 757,000.00 |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | -650,000.00 |
| Mar 31, 2022 | -606,000.00 |